BEAT
$60.19
Biotelemetry
($1.49)
(2.42%)
BEAT
Earnings Whisper ®
N/A
4th Quarter December 2018
Consensus:  $0.39
Revenue:  $101.18 Mil
Tuesday
Jan 29
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when BEAT reports earnings?
Beat
Meet
Miss

Where is BEAT's stock price going from here?
Up
Flat
Down
Stock chart of BEAT
Analysts
Summary of analysts' recommendations for BEAT
Score
Grade
Pivots
Resistance
$66.59
$64.78
$62.49

$60.68

Support
$58.39
$56.58
$54.29
Tweet
Growth
Description
BioTelemetry, Inc. provides ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. It is focused on the diagnosis and monitoring of cardiac arrhythmias, or heart rhythm disorders. BioTelemetry, Inc., formerly known as CardioNet, Inc., is headquartered in Conshohocken, Pennsylvania.
Peers
Laboratory Corp. of AmericaQuest Diagnostics